| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/07/1999 | WO1998040049A3 Specific magnetosome, method for the production and use thereof |
| 01/07/1999 | WO1998039464A3 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 01/07/1999 | WO1998035048A3 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 01/07/1999 | EP0889132A2 Streptococcus pneumoniae gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889131A2 Staphylococcus aureus gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889127A1 Serine/threonine protein kinase (H-SGK2) |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889122A2 Inhibition of DNA Methyltransferase |
| 01/07/1999 | EP0888776A1 A product of heat treatment of uronic acid, food, drink or drug including the product |
| 01/07/1999 | EP0888457A1 Adeno-associated virus vector for boosting immunogenicity of cells |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888374A1 High affinity nucleic acid ligands of complement system proteins |
| 01/07/1999 | EP0888370A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/07/1999 | EP0888353A1 Novel n-7-heterocyclyl pyrrolo 2,3-d]pyridines and their use |
| 01/07/1999 | EP0888352A1 Fused imidazole derivatives as multidrug resistance modulators |
| 01/07/1999 | EP0888351A1 Pyrimido 5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production |
| 01/07/1999 | EP0888349A1 Pyrrolopyrimidines and processes for their preparation |
| 01/07/1999 | EP0888344A1 Spirocycle integrin inhibitors |
| 01/07/1999 | EP0888340A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 01/07/1999 | EP0888326A2 Novel ortho-naphthoquinone derivatives, novel synthesis therefor, and their use in the inhibition of neoplastic cell growth |
| 01/07/1999 | EP0888301A1 Mcbi analogs of cc-1065 and the duocarmycins |
| 01/07/1999 | EP0888298A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/07/1999 | EP0888126A1 Anti-idiotypic antibody vaccines |
| 01/07/1999 | EP0888125A1 Glycosylated humanized b-cell specific antibodies |
| 01/07/1999 | EP0888122A1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 01/07/1999 | EP0698040A4 Lhrh antagonists |
| 01/07/1999 | DE19728524A1 Cyclische Azapeptide Cyclic Azapeptide |
| 01/07/1999 | DE19728436A1 Niedrigdosierte 15-Desoxyspergualin-Präparate Low-dose 15-deoxyspergualin preparations |
| 01/07/1999 | CA2765222A1 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 01/07/1999 | CA2665707A1 Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum |
| 01/07/1999 | CA2295925A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | CA2295311A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | CA2295303A1 Human nk-3 related prostate specific gene-1 |
| 01/07/1999 | CA2295229A1 Induction of an activated myeloid dendritic cell phenotype |
| 01/07/1999 | CA2294250A1 Bis-indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them |
| 01/07/1999 | CA2294232A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 01/07/1999 | CA2294131A1 Site-directed chemotherapy of metastases |
| 01/07/1999 | CA2292379A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 01/07/1999 | CA2290364A1 Method of producing tiazofurin and other c-nucleosides |
| 01/06/1999 | CN1204342A Antineoplastic peptides |
| 01/06/1999 | CN1204320A Alpha-substituted arylsulphonamido hydroxamic acids as TNF-alpha and matrix metalloproteinase inhibitors |
| 01/06/1999 | CN1203948A Promoter of human endoglin gene and its use |
| 01/06/1999 | CN1203815A Anticanser medicine |
| 01/06/1999 | CN1203798A Oral Chinese medicine composition for curing gastric cancer |
| 01/05/1999 | US5856580 Cleavage of an oxybride |
| 01/05/1999 | US5856574 Ortho-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/05/1999 | US5856535 Viricides; anticancer agents; antiangiogenic agents |
| 01/05/1999 | US5856532 Isolating the xyloside analogue of taxols from stem bark of taxus wallichiana, extracting, heating, precipitating, dissolving in a solvent, cleaving diol of xyloside to dialdehyde, reducing, acetylating, protecting, deprotecting |
| 01/05/1999 | US5856517 Substituted pyrroles |
| 01/05/1999 | US5856506 (oxazolylcarbonylamino)ethylamino glutamate derivatives |
| 01/05/1999 | US5856490 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity |
| 01/05/1999 | US5856461 Antibody |
| 01/05/1999 | US5856439 Farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same |
| 01/05/1999 | US5856354 Tachykinin antagonists |
| 01/05/1999 | US5856349 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 01/05/1999 | US5856344 Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic aid, and medicament containing them |
| 01/05/1999 | US5856333 Substituted camptothecin derivatives and process for their preparation |
| 01/05/1999 | US5856330 Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
| 01/05/1999 | US5856302 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 01/05/1999 | US5856187 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/05/1999 | US5856171 Cell death regulators |
| 01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
| 01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/05/1999 | US5856098 Detection of this receptor variant in cells of obese individuals, and methods for treating obesity by targeting variant. |
| 01/05/1999 | US5856091 Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 |
| 01/05/1999 | US5855921 Removing deuterium from aqueous solution; administering |
| 01/05/1999 | US5855919 Method using keyhole limpet hemocyanin composition with enhanced immunogenic activity |
| 01/05/1999 | US5855911 Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides |
| 01/05/1999 | US5855891 Ichimeric papillomavirus-like particles |
| 01/05/1999 | US5855867 Radiological imaging |
| 01/05/1999 | US5855866 Constructs designed to have a cytotoxic or otherwise anticellular effect against tumor vasculature |
| 01/05/1999 | CA2005880C Macrocyclic aminophosphonic acid complexes, their preparation formulations and use |
| 01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
| 01/01/1999 | CA2236441A1 Gida2 |
| 01/01/1999 | CA2236435A1 Gida2 |
| 01/01/1999 | CA2235785A1 Serine/threonine protein kinase (h-sgk2) |
| 12/30/1998 | WO1998059065A1 Novel method of dna transfer into cells |
| 12/30/1998 | WO1998059040A2 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 12/30/1998 | WO1998058964A1 Methods and compositions for galactosylated glycoproteins |
| 12/30/1998 | WO1998058944A1 Compositions and methods for activating genes of interest |
| 12/30/1998 | WO1998058927A1 Soluble prodrugs of paclitaxel |
| 12/30/1998 | WO1998058926A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
| 12/30/1998 | WO1998058925A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 12/30/1998 | WO1998058919A1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 12/30/1998 | WO1998058916A1 NEW β-AMINO AND β-AZIDOCARBOXYLIC ACID DERIVATIVES, THE PRODUCTION THEREOF AND THE USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS |
| 12/30/1998 | WO1998058913A1 Chalcones having antiproliferative activity |
| 12/30/1998 | WO1998058679A1 Use of intravenous contrast agents and devices for projection mammography |
| 12/30/1998 | WO1998058678A1 Anti-cd40l immunotoxins for the treatment of diseases |
| 12/30/1998 | WO1998058676A1 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative |
| 12/30/1998 | WO1998058673A1 Nanoscale particles having an iron oxide-containing core enveloped by at least two shells |
| 12/30/1998 | WO1998058639A1 Synergistically acting compositions for selectively combating tumor tissue |
| 12/30/1998 | WO1998058635A2 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis |
| 12/30/1998 | WO1998058585A1 Device for projection mammography |
| 12/30/1998 | WO1998040404A3 Secreted proteins and polynucleotides encoding them |
| 12/30/1998 | EP0887416A2 Human AFC1 |
| 12/30/1998 | EP0887415A2 Human RCE1 |
| 12/30/1998 | EP0887408A1 Wnt-3 oncogene: polypeptides and polynucleotides |
| 12/30/1998 | EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor |
| 12/30/1998 | EP0887406A2 A member of the FRZB family, franzzled |
| 12/30/1998 | EP0887348A1 Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them |